Abstract
Infection with Helicobacter pylori is associatedwith the development of gastric cancer. To study whetherthe infection with H. pylori strains expressing thevacuolating cytotoxin (VacA) and/or thecytotoxin-associated protein (CagA) is associated with an increasedrisk of developing gastric adenocarcinoma, sera of 90patients with gastric cancer and 90 matched controlswith cardiovascular diseases were investigated for the presence of antibodies to VacA and CagA byimmunoblot. Although no significant difference in theoverall H. pylori seropositivity was found betweencancer patients and controls, antibodies against VacA or CagA were significantly more frequent incancer patients than in control subjects. Seventyfive(97.4%) of 77 H. pylori-positive patients in the cancergroup, but only 60 (84.5%) of 71 H. pylori-positive control patients had antibodies against eitherVacA or CagA (χ2 6.63; relative risk,2.00; 95% confidence interval, 1.18–3.39; P =0.01). The presence of antibodies against VacA or CagAalone was also associated with an increased cancer risk (92.2%vs 80.3%; χ2 = 5.30; relative risk, 1.74;95% confidence interval, 1.08–2.78; P = 0.021, forVacA; and 87.0% vs 74.6%; χ2 4.90;relative risk, 1.61; 95% confidence interval, 1.06–2.45; P =0.037, for CagA). The relative risk for gastric cancerwas mainly elevated in patients under 65 years, but notin patients at or over 65 years. There is evidence that infection with VacA- or CagA-producing H.pylori strains increases the risk of developing gastriccancer, especially in younger patients.
Similar content being viewed by others
REFERENCES
Parkin DM, Laara E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184–97, 1988
Correa P, Haenszel W: Epidemiology of gastric cancer. In Epidemiology of Cancer of the Digestive Tract. P Correa, W Haenszel (eds). The Hague, M. Nijhoff, 1982, pp 58–84
Joossens JV, Geboers J: Diet and environment in the etiology of gastric cancer. In Frontiers in Gastrointestinal Cancer. B Levin, RH Riddell (eds). New York, Elsevier, 1984, pp 168–183
Forman D, Newell DG, Fullerton F, Yarnell JGW, Stacey AR, Wald N, Sitas F: Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 302:1302–1305, 1991
Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ: Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 83:1734–1739, 1991
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orenteich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131, 1991
Nomura A, Stemmermann GN, Chyou P-H, Kato I, Perez-Perez GI, Blaser MJ: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132–1136, 1991
Hansson L-E, Engstrand L, Nyren O, Evans DJ, Lindgren A, Bergström R, Andersson B, Athlin L, Bendtsen O, Tracz P: Helicobacter pylori infection: Independent risk factor of gastric adenocarcinoma. Gastroenterology 105:1098–1103, 1993
The Eurogast Study Group: An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:1359–1362, 1993
Taylor DN, Blaser MJ: The epidemiology of Helicobacter pylori infection. Epidemiol Rev 13:42–59, 1991
Cover T, Dooley C, Blaser M: Characterisation of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 58:603–610, 1990
Phadnis SH, Ilver D, Janzon L, Normark S, Westblom TU: Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 62:1557–1565, 1994
Schmitt W, Haas R: Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: Structural similarities with the IgA protease type of exported protein. Mol Microbiol 12:307–319, 1994
Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, Russi M, Quaranta SI: Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis. J Clin Microbiol 27:225–226, 1989
Goossens H, Glupczynski Y, Burette A, Lambert J-P, Vlaes L, Butzler J-P: Role of the vacuolating toxin form Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer. Med Microbiol Lett 1:153–159, 1992
Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, Rappuoli RI: Molecular characterization of the 128-kDa immunodominat antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 90:5791–5795, 1993
Tummuru MK, Cover TL, Blaser MJ: Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun 61:1799–1809, 1993
Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ: Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet 59:1264–1270, 1991
Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MKR, Perez-Perez GI, Blaser MJ: Serologic detection of infection with cagA + Helicobacter pylori strains. J Clin Microbiol 33:1496–1500, 1995
Apel I, Jacobs E, Kist M, Bredt W: Antibody response of patients against a 120-kDa surface protein of Campylobacter pylori. Zentralbl Bakteriol Hyg A 268:271–276, 1988
Crabtree JE, Wyatt JI, Sobala GM, Tompkins DS, Primrose JN, Morgan AG: Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 34:1339–1343, 1993
Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111–2115, 1995
Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N: High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer 56:56–60, 1994
Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31–49, 1965
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275, 1951
Feldman RA, Deeks JJ, Evans SJW, Helicobacter pylori Serology Study Group: Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Eur J Clin Microbiol Infect Dis 14:428–433, 1995
Laemmli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680–685, 1970
Pena AS, Endtz HP, Offerhaus GJA, Hoogenboom-Verdegaal A, van Duijn W, de Vargas N, den Hartog G, Kreuning J, van der Reyden J, Mouton RP, Lamers CBHW: Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion 44:131–141, 1989
Crabtree JE, Mahony MJ, Taylor JD, Heatley RV, Littlewood JM, Tompkins DS: Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol 44:768–771, 1991
SAS Institute Inc: SAS/STAT™ User's Guide for Personal Computers. Version 6.03, Cary, (North Carolina), SAS Institute, 1988, 1028 pp
Rudi J, Müller M, von Herbay A, Zuna I, Raedsch R, Stremmel W, Räth U: Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Scand J Gastroenterol 30:958–963, 1995
Weel JFL, van der Hulst RWM, Gerrits Y, Roorde P, Feller M, Dankert J, Tytgat GNJ, van der Ende A. The interrelationsship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 173:1171–1175, 1996
Cover TL, Cao P, Lind CD, Tham KT, Blaser MJ: Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 61:5008–5012, 1993
Correa P. Human gastric carcinogenesis: A multistep and multifactorial process—First American Cancer Society lecture on cancer epidemiology and prevention. Cancer Res 52:6735–6740, 1992
Fox JG, Correa P, Taylor NS, Thompson N, Fontham E, Janney F, Sobhan M, Ruiz B, Hunter F: High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 87:1554–1560, 1992
Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 270:17771–17777, 1995
Sipponen P, Kosunen TU, Valle J, Riihela M, Seppala K: Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 33:1029–1032, 1992
Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y: Helicobacter pylori infection in intestinal-and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 83:640–643, 1991
Loffeld RJLF, Willems I, Flendrig JA, Arends JW: Helicobacter pylori and gastric carcinoma. Histopathology 17:537–541, 1990
Asaka M, Kimura T, Kato M, Kudo K, Miki K, Ogoshi K, Kato T, Tatsuta M, Graham DY: Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 73:2691–2694, 1994
Endo S, Ohkusa T, Saito Y, Fujiki K, Okayasu I, Sato C: Detection of Helicobacter pylori infection in early stage gastric cancer. Cancer 75:2203–2208, 1995
Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437–439, 1994
Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfield TC: Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 311:711–714, 1995
Ponzetto A, La Rovere MT, Sanseverion P, Bazzoli F: Association of Helicobacter pylori infection with coronary heart disease. Study confirms previous findings. Br Med J 312:251, 1996 (letter)
Delaney BC, Hobbs FDR, Holder R: Association of Helicobacter pylori infection with coronary heart disease. Eradication of the infection on grounds of cardiovascular risk is not supported by current evidence. Br Med J 312:251–252, 1996 (letter)
Murray LJ, Bamford KB, O'Reilly DPJ, McCrum EE, Evans AE: Helicobacter pylori: Relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 74:497–501, 1995
McDonagh TA, Woodward M, Morrison C, McMurray J, Tunstall-Pedae H, Lowe GDO, Dargie HJ, McColl KEL: Lack of independent association of H. pylori and coronary heart disease. Gastroenterology 110(suppl):A190, 1996 (abstract)
Maier F, Auricchio A, Nilius M, Klein H, Malfertheiner P: Lack of association between Helicobacter pylori infection and angiographically documented coronary heart disease. Gastroenterology 110(suppl):A193, 1996 (abstract)
Khursid A, Puetz T, Fenske T, Bajwa T, Vakil N: Seroprevalence of Helicobacter pylori infection in patients with and without angiographic evidence of coronary heart disease. Gastroenterology 110(Suppl):A154, 1996 (abstract)
Sandifer Q, Vuilo S, Crompton G: Association of Helicobacter pylori infection with coronary heart disease. Association may not be crucial. Br Med J 312:251, 1996 (letter).
Rights and permissions
About this article
Cite this article
Rudi, J., Kolb, C., Maiwald, M. et al. Serum Antibodies Against Helicobacter pylori Proteins VacA and CagA Are Associated with Increased Risk for Gastric Adenocarcinoma. Dig Dis Sci 42, 1652–1659 (1997). https://doi.org/10.1023/A:1018849112533
Issue Date:
DOI: https://doi.org/10.1023/A:1018849112533